TY - JOUR
T1 - Prognostic value of right ventricular longitudinal strain assessed by multimodal imaging in amyloidosis
T2 - systematic review and meta-analysis
AU - Herrera-Flores, Javier
AU - Vernooij, Robin W.M.
AU - Ghosh, Arjun K.
AU - Wechalekar, Ashutosh
AU - Cheng, Richard K.
AU - Keramida, Kalliopi
AU - Anguita, Manuel
AU - Sanchez, Pedro L.
AU - Perez Del Villar, Candelas
AU - Herrera-Flores, Cristian
N1 - Publisher Copyright:
© 2025 The Author(s). Published by Oxford University Press on behalf of the European Society of Cardiology. All rights reserved. For commercial re-use, please contact [email protected] for reprints and translation rights for reprints. All other permissions can be obtained through our RightsLink service via the Permissions link on the article page on our site - for further information please contact [email protected].
PY - 2025/10/1
Y1 - 2025/10/1
N2 - Aims Amyloidosis is a progressive and often fatal disease, with right ventricular (RV) involvement emerging as critical determinant of outcomes. This meta-analysis sought to evaluate the prognostic significance of RV longitudinal strain parameters in patients with amyloidosis. Methods and results Eligible studies reporting on the association between RV free-wall longitudinal strain (RV-FWLS) and RV global longitudinal strain (RV-GLS) assessed by echocardiography or cardiac magnetic resonance (CMR) with adverse outcomes were included. Using an inversely weighted random-effects meta-analysis, pooled hazard ratios (HRs) with 95% confidence intervals (CIs) were calculated for all-cause mortality and a composite endpoint of all-cause death or heart failure hospitalization per 1% lower RV strain values. Eighteen studies with low-to-moderate risk of bias (Newcastle-Ottawa scale) and encompassing 1772 patients [mean age 68.8 ± 8.8 years; 57.3% with light-chain amyloidosis (AL)], were analysed. 210 patients experienced the composite outcome (median [inter-quartile range] follow-up: 1.5 [0.6] years) and 628 died [median follow-up: 2.6 (1.6) years]. 2D speckle-tracking RV-FWLS was associated with all-cause mortality (HR: 1.10; 95% CI: 1.07-1.13; I² = 8.6%) and the composite outcome (HR: 1.06; 95% CI: 1.02-1.10; I² = 0%). Similarly, 2D speckle-tracking RV-GLS was associated with all-cause mortality (HR: 1.10; 95% CI: 1.07-1.13; I² = 8.6%). Subgroup and meta-regression analysis confirmed consistency across amyloid subtypes, study design, presence of cardiac involvement, follow-up duration, and strain analysis software. In AL amyloidosis, CMR-based RV-GLS also predicted all-cause mortality (HR: 1.06; 95% CI: 1.03-1.09; I² = 0%). Conclusion RV longitudinal strain parameters are powerful and robust predictors of adverse outcomes in amyloidosis.
AB - Aims Amyloidosis is a progressive and often fatal disease, with right ventricular (RV) involvement emerging as critical determinant of outcomes. This meta-analysis sought to evaluate the prognostic significance of RV longitudinal strain parameters in patients with amyloidosis. Methods and results Eligible studies reporting on the association between RV free-wall longitudinal strain (RV-FWLS) and RV global longitudinal strain (RV-GLS) assessed by echocardiography or cardiac magnetic resonance (CMR) with adverse outcomes were included. Using an inversely weighted random-effects meta-analysis, pooled hazard ratios (HRs) with 95% confidence intervals (CIs) were calculated for all-cause mortality and a composite endpoint of all-cause death or heart failure hospitalization per 1% lower RV strain values. Eighteen studies with low-to-moderate risk of bias (Newcastle-Ottawa scale) and encompassing 1772 patients [mean age 68.8 ± 8.8 years; 57.3% with light-chain amyloidosis (AL)], were analysed. 210 patients experienced the composite outcome (median [inter-quartile range] follow-up: 1.5 [0.6] years) and 628 died [median follow-up: 2.6 (1.6) years]. 2D speckle-tracking RV-FWLS was associated with all-cause mortality (HR: 1.10; 95% CI: 1.07-1.13; I² = 8.6%) and the composite outcome (HR: 1.06; 95% CI: 1.02-1.10; I² = 0%). Similarly, 2D speckle-tracking RV-GLS was associated with all-cause mortality (HR: 1.10; 95% CI: 1.07-1.13; I² = 8.6%). Subgroup and meta-regression analysis confirmed consistency across amyloid subtypes, study design, presence of cardiac involvement, follow-up duration, and strain analysis software. In AL amyloidosis, CMR-based RV-GLS also predicted all-cause mortality (HR: 1.06; 95% CI: 1.03-1.09; I² = 0%). Conclusion RV longitudinal strain parameters are powerful and robust predictors of adverse outcomes in amyloidosis.
KW - amyloidosis
KW - cardiac amyloidosis
KW - heart failure
KW - mortality
KW - outcomes
KW - right ventricular free-wall longitudinal strain
KW - right ventricular global longitudinal strain
UR - https://www.scopus.com/pages/publications/105017447274
U2 - 10.1093/ehjci/jeaf216
DO - 10.1093/ehjci/jeaf216
M3 - Article
C2 - 40795094
AN - SCOPUS:105017447274
SN - 2047-2404
VL - 26
SP - 1644
EP - 1661
JO - European Heart Journal Cardiovascular Imaging
JF - European Heart Journal Cardiovascular Imaging
IS - 10
ER -